Comments

Taysha Gene Therapies

Q: What sector and industry does Taysha Gene Therapies (TSHA) operate in?

Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TSHANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q3 2024 Earnings were released on Wed Nov 13th, after the market close

The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast

Taysha Gene Therapies (TSHA) Forecast

News Earnings Taysha Gene Therapies (TSHA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Taysha Gene Therapies (NASDAQ:TSHA) Stock Quotes, Forecast and News Summary

Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.

Open	$2.12
Close	-
Volume / Avg.	320.18K / 3.01M
Day Range	$2.02 - $2.12
52 Wk Range	1.19 - 4.32
Market Cap	$421.16M
P/E Ratio	3.37
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	11.36%
Days to Cover	11.01

Recent News

Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

Neurogene (NASDAQ:NGNE) stock just took a sharp dive, plummeting 44% in a single day. Bad news on Monday caused the pharmaceutical company’s shares to drop massively in after-hours trading, and they continued to

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.12
Close	-
Volume / Avg.	320.18K / 3.01M
Day Range	$2.02 - $2.12
52 Wk Range	1.19 - 4.32
Market Cap	$421.16M
P/E Ratio	3.37
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	11.36%
Days to Cover	11.01

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Taysha Gene Therapies (TSHA) stock?

You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.

View our list of the best stock brokerages

Who are Taysha Gene Therapies (TSHA) competitors?

Other companies in Taysha Gene Therapies’s space includes: KalVista Pharma (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).

What is the forecast, or price target, for Taysha Gene Therapies (TSHA) stock?

Taysha Gene Therapies has a consensus price target of $7.25.

What is the current price for Taysha Gene Therapies (TSHA)?

The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.13 last updated November 20, 2024 at 9:29 AM EST.

Does Taysha Gene Therapies (TSHA) pay a dividend?

There are no upcoming dividends for Taysha Gene Therapies.

When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?

Taysha Gene Therapies’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Taysha Gene Therapies (TSHA) going to split?

There is no upcoming split for Taysha Gene Therapies.

What sector and industry does Taysha Gene Therapies (TSHA) operate in?

Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.